These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

115 related articles for article (PubMed ID: 15122749)

  • 1. Short-term interferon-alfa therapy for acute hepatitis C: a randomized controlled trial.
    Nomura H; Sou S; Tanimoto H; Nagahama T; Kimura Y; Hayashi J; Ishibashi H; Kashiwagi S
    Hepatology; 2004 May; 39(5):1213-9. PubMed ID: 15122749
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Short-term interferon therapy for chronic hepatitis C patients with low viral load.
    Sato Y; Tokuue H; Kawamura N; Nezu-Yajima S; Nakajima H; Ishida H; Takahashi S
    Hepatogastroenterology; 2004; 51(58):968-72. PubMed ID: 15239226
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Interferon-alpha therapy within the first year after acute hepatitis C infection in hemodialysis patients: efficacy and tolerance.
    Rocha CM; Perez RM; Narciso JL; Ferreira AP; Lemos LB; Medina-Pestana JO; Silva AE; Ferraz ML
    Eur J Gastroenterol Hepatol; 2007 Feb; 19(2):119-23. PubMed ID: 17272996
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Long-term follow-up after successful interferon therapy of acute hepatitis C.
    Wiegand J; Jäckel E; Cornberg M; Hinrichsen H; Dietrich M; Kroeger J; Fritsch WP; Kubitschke A; Aslan N; Tillmann HL; Manns MP; Wedemeyer H
    Hepatology; 2004 Jul; 40(1):98-107. PubMed ID: 15239091
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Chronic hepatitis C virus infection in renal transplant: treatment and outcome.
    Sharma RK; Bansal SB; Gupta A; Gulati S; Kumar A; Prasad N
    Clin Transplant; 2006; 20(6):677-83. PubMed ID: 17100715
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Effectiveness of lamivudine and interferon-alpha combination therapy versus interferon-alpha monotherapy for the treatment of HBeAg-negative chronic hepatitis B patients: a randomized clinical trial.
    Karabay O; Tamer A; Tahtaci M; Vardi S; Celebi H
    J Microbiol Immunol Infect; 2005 Aug; 38(4):262-6. PubMed ID: 16118673
    [TBL] [Abstract][Full Text] [Related]  

  • 7. [Effect of hepatitis C virus serotype on the response of patients with chronic hepatitis C to interferon treatment].
    Chen LJ; Li MH; Xie Y; Xu DZ
    Zhonghua Shi Yan He Lin Chuang Bing Du Xue Za Zhi; 2007 Jun; 21(2):117-9. PubMed ID: 17653309
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Alpha-interferon with ribavirin in the treatment of hemodialysis patients with hepatitis C.
    Mousa DH; Abdalla AH; Al-Shoail G; Al-Sulaiman MH; Al-Hawas FA; Al-Khader AA
    Transplant Proc; 2004; 36(6):1831-4. PubMed ID: 15350490
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Three times weekly versus daily dose alpha-interferon treatment in patients with acute hepatitis C.
    Fabris P; Tositti G; Giordani MT; Infantolino D; de LF
    Am J Gastroenterol; 2002 Feb; 97(2):492-3. PubMed ID: 11866300
    [No Abstract]   [Full Text] [Related]  

  • 10. Natural beta interferon in acute type-C hepatitis patients: a randomized controlled trial.
    Calleri G; Colombatto P; Gozzelino M; Chieppa F; Romano P; Delmastro B; Macor A; Cariti G; Brunetto MR; Grillone W; Bonino F
    Ital J Gastroenterol Hepatol; 1998 Apr; 30(2):181-4. PubMed ID: 9675655
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Therapy of hepatitis C.
    Fried MW; Hoofnagle JH
    Semin Liver Dis; 1995 Feb; 15(1):82-91. PubMed ID: 7597447
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Interferon treatment in acute progressive and fulminant hepatitis.
    Levin S; Leibowitz E; Torten J; Hahn T
    Isr J Med Sci; 1989 Jul; 25(7):364-72. PubMed ID: 2474521
    [TBL] [Abstract][Full Text] [Related]  

  • 13. [Peripheral neuropathy during a second cycle of treatment with high doses of interferon-alpha in a patient with hepatitis C, and a review of the literature].
    Téllez-Zenteno JF; Negrete-Pulido O; Nuñez M; Estañol-Vidal B; García-Ramos G
    Rev Neurol; 2002 Oct 1-15; 35(7):644-6. PubMed ID: 12389150
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Serum concentration of interferon-alpha: a comparison between once-a-day and twice-a-day administration.
    Matsukawa Y; Nishinarita S; Horie T; Moriyama M; Tanaka N; Arakawa Y; Kamei S; Matsuura M; Kojima T
    Int J Clin Pharmacol Res; 2000; 20(1-2):17-9. PubMed ID: 11146898
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Severe exacerbation of hepatitis C-associated vasculitic neuropathy following treatment with interferon alpha: a case report and literature review.
    Boonyapisit K; Katirji B
    Muscle Nerve; 2002 Jun; 25(6):909-13. PubMed ID: 12115983
    [TBL] [Abstract][Full Text] [Related]  

  • 16. [Sustained virologic response after two months antiviral treatment in two patients suffering from chronic hepatitis C].
    d'Alteroche L; Bacq Y; Barbereau D; de Muret A; Dubois F
    Gastroenterol Clin Biol; 2003 Oct; 27(10):946-7. PubMed ID: 14631313
    [No Abstract]   [Full Text] [Related]  

  • 17. Interferon-induced anosmia in a patient with chronic hepatitis C.
    Maruyama S; Hirayama C; Kadowaki Y; Sagayama A; Omura H; Nakamoto M
    Am J Gastroenterol; 1998 Jan; 93(1):122-3. PubMed ID: 9448193
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Treatment of acute hepatitis C with interferon alfa-2b.
    Patel R; Germer JJ
    N Engl J Med; 2002 Apr; 346(14):1091-2. PubMed ID: 11932480
    [No Abstract]   [Full Text] [Related]  

  • 19. [Acute hepatitis C: a retrospective study of 62 cases].
    Morin T; Pariente A
    Gastroenterol Clin Biol; 2002 Nov; 26(11):994-1000. PubMed ID: 12483131
    [TBL] [Abstract][Full Text] [Related]  

  • 20. [Treatment of chronic hepatitis C with IFN].
    Matsushima T
    Hokkaido Igaku Zasshi; 1993 Jul; 68(4):468-72. PubMed ID: 8393421
    [No Abstract]   [Full Text] [Related]  

    [Next]    [New Search]
    of 6.